Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 64,179 | 74,141 | 66,865 | 68,914 | 79,025 |
| Cost of Goods | 38,335 | 35,108 | 36,686 | 43,273 | 33,676 |
| Gross Profit | 25,844 | 39,033 | 30,179 | 25,641 | 45,349 |
| Operating Expenses | 45,040 | 46,291 | 46,282 | 37,528 | 43,492 |
| Operating Income | -18,861 | -7,150 | -15,417 | -11,614 | 2,533 |
| Interest Expense | 10,864 | 15,400 | 11,637 | 7,022 | 11,833 |
| Other Income | 7,316 | 678,736 | 6,491 | 5,272 | 4,777 |
| Pre-tax Income | -22,409 | 656,186 | -20,563 | -13,364 | -4,523 |
| Income Tax | 271 | 766,168 | -5,461 | -1,421 | -3,175 |
| Net Income Continuous | -22,680 | -109,982 | -15,102 | -11,943 | -1,348 |
| Minority Interests | -10,602 | -4,023 | -8,640 | -5,402 | -1,281 |
| Net Income | $-12,078 | $-105,959 | $-6,462 | $-6,541 | $-67 |
| EPS Basic Total Ops | -0.09 | -0.80 | -0.05 | -0.05 | 0.00 |
| EPS Basic Continuous Ops | -0.17 | -0.83 | -0.11 | -0.09 | -0.01 |
| EPS Diluted Total Ops | -0.09 | -0.80 | -0.05 | -0.05 | 0.00 |
| EPS Diluted Continuous Ops | -0.17 | -0.83 | -0.11 | -0.09 | -0.01 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.05 | -0.02 | -0.06 | 0.03 |
| EBITDA(a) | $-4,368 | $6,573 | $-1,583 | $913 | $14,159 |